String of successful trials in SLE: have we cracked the code?
Author:
Publisher
BMJ
Subject
Immunology,General Medicine
Reference13 articles.
1. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study;van Vollenhoven;Lancet,2018
2. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial;Wallace;Lancet,2018
3. Hermann V , Batalov A , Smakotina S , et al . First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study. Lupus Sci Med 2019;6:e000354.doi:10.1136/lupus-2019-000354
4. Riggs JM , Hanna RN , Rajan B , et al . Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. Lupus Sci Med 2018;5:e000261.doi:10.1136/lupus-2018-000261
5. Morand EF , Furie R , Tanaka Y , et al . Trial of Anifrolumab in active systemic lupus erythematosus. N Engl J Med 2019. doi:doi:10.1056/NEJMoa1912196
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SLE is not a one-size-fits-all disease;Journal of Experimental Medicine;2023-04-25
2. Immunopathogenesis of systemic lupus erythematosus;Translational Autoimmunity;2023
3. The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases;International Journal of Molecular Sciences;2021-10-19
4. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors;Rheumatology;2020-12
5. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis;New England Journal of Medicine;2020-10-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3